181 related articles for article (PubMed ID: 30096423)
1. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.
Oni-Orisan A; Cresci S; Jones PG; Theken KN; Spertus JA; Lee CR
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():15-22. PubMed ID: 30096423
[TBL] [Abstract][Full Text] [Related]
2. Association of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgery.
Shuey MM; Billings FT; Wei S; Milne GL; Nian H; Yu C; Brown NJ
PLoS One; 2017; 12(5):e0175292. PubMed ID: 28552948
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans.
Lee CR; Pretorius M; Schuck RN; Burch LH; Bartlett J; Williams SM; Zeldin DC; Brown NJ
Hypertension; 2011 Jan; 57(1):116-22. PubMed ID: 21098312
[TBL] [Abstract][Full Text] [Related]
4. Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans.
Ramirez CE; Shuey MM; Milne GL; Gilbert K; Hui N; Yu C; Luther JM; Brown NJ
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():38-44. PubMed ID: 25173047
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.
Koerner IP; Jacks R; DeBarber AE; Koop D; Mao P; Grant DF; Alkayed NJ
J Neurosci; 2007 Apr; 27(17):4642-9. PubMed ID: 17460077
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.
Lee CR; North KE; Bray MS; Fornage M; Seubert JM; Newman JW; Hammock BD; Couper DJ; Heiss G; Zeldin DC
Hum Mol Genet; 2006 May; 15(10):1640-9. PubMed ID: 16595607
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study.
Burdon KP; Lehtinen AB; Langefeld CD; Carr JJ; Rich SS; Freedman BI; Herrington D; Bowden DW
Diab Vasc Dis Res; 2008 Jun; 5(2):128-34. PubMed ID: 18537101
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.
Cresci S; Dorn GW; Jones PG; Beitelshees AL; Li AY; Lenzini PA; Province MA; Spertus JA; Lanfear DE
J Am Coll Cardiol; 2012 Sep; 60(10):898-907. PubMed ID: 22703928
[TBL] [Abstract][Full Text] [Related]
9. Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes.
Fava C; Montagnana M; Danese E; Almgren P; Hedblad B; Engström G; Berglund G; Minuz P; Melander O
Pharmacogenet Genomics; 2010 Feb; 20(2):94-103. PubMed ID: 20065888
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: The Coronary Artery Risk Development in Young Adults (CARDIA) study.
Fornage M; Boerwinkle E; Doris PA; Jacobs D; Liu K; Wong ND
Circulation; 2004 Jan; 109(3):335-9. PubMed ID: 14732757
[TBL] [Abstract][Full Text] [Related]
11. Association of rs11780592 Polymorphism in the Human Soluble Epoxide Hydrolase Gene (EPHX2) with Oxidized LDL and Mortality in Patients with Diabetic Chronic Kidney Disease.
Roumeliotis S; Roumeliotis A; Stamou A; Panagoutsos S; Manolopoulos VG; Tsetsos F; Georgitsi M; Liakopoulos V
Oxid Med Cell Longev; 2021; 2021():8817502. PubMed ID: 34040693
[TBL] [Abstract][Full Text] [Related]
12. A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank.
Zhu X; Li Y; Yu T; Li S; Chen M
Gene; 2022 May; 822():146340. PubMed ID: 35183688
[TBL] [Abstract][Full Text] [Related]
13. The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.
Fornage M; Lee CR; Doris PA; Bray MS; Heiss G; Zeldin DC; Boerwinkle E
Hum Mol Genet; 2005 Oct; 14(19):2829-37. PubMed ID: 16115816
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
15. Missense Genetic Polymorphisms of Microsomal (
Can Demirdöğen B; Miçooğulları Y; Türkanoğlu Özçelik A; Adalı O
Neuropsychiatr Dis Treat; 2020; 16():3251-3265. PubMed ID: 33994786
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in human soluble epoxide hydrolase.
Przybyla-Zawislak BD; Srivastava PK; Vazquez-Matias J; Mohrenweiser HW; Maxwell JE; Hammock BD; Bradbury JA; Enayetallah AE; Zeldin DC; Grant DF
Mol Pharmacol; 2003 Aug; 64(2):482-90. PubMed ID: 12869654
[TBL] [Abstract][Full Text] [Related]
17. Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking.
Wei Q; Doris PA; Pollizotto MV; Boerwinkle E; Jacobs DR; Siscovick DS; Fornage M
Atherosclerosis; 2007 Jan; 190(1):26-34. PubMed ID: 16545818
[TBL] [Abstract][Full Text] [Related]
18. Epoxyeicosatrienoic Acids are Mediated by EPHX2 Variants and may be a Predictor of Early Neurological Deterioration in Acute Minor Ischemic Stroke.
Yi X; Lin J; Li J; Zhou Q; Han Z
J Atheroscler Thromb; 2017 Dec; 24(12):1258-1266. PubMed ID: 28835580
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans.
Gschwendtner A; Ripke S; Freilinger T; Lichtner P; Müller-Myhsok B; Wichmann HE; Meitinger T; Dichgans M
Stroke; 2008 May; 39(5):1593-6. PubMed ID: 18323494
[TBL] [Abstract][Full Text] [Related]
20. No impact of soluble epoxide hydrolase rs4149243, rs2234914 and rs751142 genetic variants on the development of type II diabetes and its hypertensive complication among Jordanian patients.
Khamees M; Jarrar Y; Al-Qirim T; Mahmoud IS; Hatmal MM; Alshaer W; Lee SJ
Int J Clin Pract; 2021 May; 75(5):e14036. PubMed ID: 33512081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
